Senior Vice President Clinical R&D – HaematologyOctapharma AGLachen, Schwyz, Switzerland
PB0584 - Using heparin-calibrated assays to assess anti-factor Xa activity of factor Xa inhibitors (FXaI): a literature correlation analysis
Monday, June 26, 202318:30 – 19:30 ET
PB0840 - Efficacy of prophylaxis with a plasma-derived von Willebrand factor/ factor VIII concentrate in patients with von Willebrand disease: Subgroup analysis by age and VWD type
PO10 - Nuwiq Dosing and outcomes In the ManagEment of women/girls with haemophilia A Needing FVIII treatment for Surgery – an International, Open-label, Non-controlled study (NuDIMENSION)
Wednesday, June 28, 202313:00 – 14:00 ET
